SCHEMBL2560656

SCHEMBL2560656

COC(=O)Cc1cc(N)ccc1Oc1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SLC1A5 Q15758 1/20 0.47
MTNR1B P49286 9/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 1/20 0.44
P2RX4 Q99571 1/20 0.44
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 1/20 0.43
BRCA1 P38398 1/20 0.43
HBB P68871 1/20 0.43
KMT2A Q03164 1/20 0.43
MTNR1A P48039 5/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2561432 0.88 HSD17B10 (0.46) KDM4ESLC1A5ALDH1A1CYP3A4MAPT
SCHEMBL2562353 0.85 KDM4E (0.52) KDM4EPOLBSMN1; SMN2SLC1A5MTNR1B
SCHEMBL8002569 0.84 MTNR1B (0.54) KDM4EPOLBSLC1A5MTNR1BALDH1A1
SCHEMBL9151951 0.83 MTNR1B (0.53) KDM4EPOLBSLC1A5MTNR1BALDH1A1
SCHEMBL9159002 0.82 HSD17B10 (0.49) KDM4EALDH1A1CYP3A4MAPTL3MBTL1
SCHEMBL9152712 0.82 MAOB (0.45) KDM4ESMN1; SMN2SLC1A5MTNR1BALDH1A1
SCHEMBL2561207 0.81 TBXA2R (0.58) KDM4EPOLBSMN1; SMN2ALDH1A1MAPT
SCHEMBL9150938 0.76 KDM4E (0.48) KDM4EPOLBSLC1A5MTNR1BALDH1A1
SCHEMBL30104106 0.74 HSD17B10 (0.73) KDM4EMTNR1BALDH1A1HSD17B10MEN1
SCHEMBL5316111 0.74 MAPT (0.66) KDM4EPOLBSMN1; SMN2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011130741-A1 COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES ARRAY BIOPHARMA INC. (US) 2011-10-20 WO disclosed